Arcus Biosciences (RCUS) Non-Current Assets (2017 - 2025)
Historic Non-Current Assets for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to $117.0 million.
- Arcus Biosciences' Non-Current Assets fell 3236.99% to $117.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $505.0 million, marking a year-over-year decrease of 4065.8%. This contributed to the annual value of $134.0 million for FY2024, which is 4924.24% down from last year.
- Arcus Biosciences' Non-Current Assets amounted to $117.0 million in Q3 2025, which was down 3236.99% from $129.0 million recorded in Q2 2025.
- Arcus Biosciences' Non-Current Assets' 5-year high stood at $330.0 million during Q4 2021, with a 5-year trough of $93.2 million in Q1 2021.
- In the last 5 years, Arcus Biosciences' Non-Current Assets had a median value of $234.0 million in 2023 and averaged $213.8 million.
- As far as peak fluctuations go, Arcus Biosciences' Non-Current Assets surged by 201878.06% in 2021, and later crashed by 4924.24% in 2024.
- Arcus Biosciences' Non-Current Assets (Quarter) stood at $330.0 million in 2021, then dropped by 29.39% to $233.0 million in 2022, then rose by 13.3% to $264.0 million in 2023, then crashed by 49.24% to $134.0 million in 2024, then dropped by 12.69% to $117.0 million in 2025.
- Its Non-Current Assets stands at $117.0 million for Q3 2025, versus $129.0 million for Q2 2025 and $125.0 million for Q1 2025.